Yantai Zhenghai Biotechnology Co., Ltd.

300653

CNE100002NZ1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 23/05/2024 am IST			5-day change	1st Jan Change
23.57 ^CNY	-4.07%		-5.00%	-18.78%

28/04	Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/04	Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	CI

Yantai Zhenghai Biotechnology Co., Ltd.(XSEC:) added to S&P Global BMI Index

September 21, 2020 at 09:30 am IST

Latest news about Yantai Zhenghai Biotechnology Co., Ltd.

Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04	CI
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	03/04	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
Zhenghai Bio-Tech Gets Nod for Oral Restorative Film	14/03	MT
Tranche Update on Yantai Zhenghai Biotechnology Co., Ltd.'s Equity Buyback Plan announced on December 20, 2023.	03/01	CI
Yantai Zhenghai Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	20/12	CI
Yantai Zhenghai Biotechnology Co., Ltd. authorizes a Buyback Plan.	20/12	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/23/23	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Zhenghai Bio-Tech Enrolls First Subject for Uterine Cavity Repair Membrane Trial	22/23/22	MT
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/22/18	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	19/21/19	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	05/21/05	CI
Yantai Zhenghai Biotechnology Co., Ltd. Approves the Board Election	01/21/01	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/21/28	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	08/21/08	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	28/20/28	CI
Yantai Zhenghai Biotechnology Co., Ltd.(XSEC:) added to S&P Global BMI Index	21/20/21	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	04/20/04	CI
Yantai Zhenghai Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	09/20/09	CI

Chart Yantai Zhenghai Biotechnology Co., Ltd.

Duration

Period

Chart Yantai Zhenghai Biotechnology Co., Ltd.

More charts

Yantai Zhenghai Bio-Tech Co Ltd is a company engaged in production and sales of implantable medical devices. The Company has two types of products which are soft tissue repair materials and hard tissue repair materials. The soft tissue repair materials include oral repair membranes, biofilms and skin repair membranes. The hard tissue repair materials include bone repair materials.

Sector

Medical Equipment, Supplies & Distribution

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Yantai Zhenghai Biotechnology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

23.57 CNY

Average target price

32.58 CNY

Spread / Average Target

+38.21%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.	-18.78%	61Cr
STRYKER CORPORATION	+10.24%	13TCr
SMITH & NEPHEW PLC	-8.89%	1.13TCr
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.31%	928.11Cr
GLAUKOS CORPORATION	+35.16%	542.31Cr
INSPIRE MEDICAL SYSTEMS, INC.	-23.90%	479.8Cr
AXONICS, INC.	+8.20%	345.04Cr
ENOVIS CORPORATION	-10.69%	279.96Cr
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.15%	209.82Cr
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-11.96%	198.41Cr

Medical Devices & Implants